Faculty of Medicine
Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14
Browse
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)(Springer Science and Business Media LLC, 2024-07-20) ;Noebauer-Huhmann, Iris-Melanie ;Vanhoenacker, Filip M ;Vilanova, Joan C ;Tagliafico, Alberto SWeber, Marc-AndréThe revised European Society of Musculoskeletal Radiology (ESSR) consensus guidelines on soft tissue tumor imaging represent an update of 2015 after technical advancements, further insights into specific entities, and revised World Health Organization (2020) and AJCC (2017) classifications. This second of three papers covers algorithms once histology is confirmed: (1) standardized whole-body staging, (2) special algorithms for non-malignant entities, and (3) multiplicity, genetic tumor syndromes, and pitfalls. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023-overview, and primary local imaging: how and where?(Springer Science and Business Media LLC, 2024-07) ;Noebauer-Huhmann, Iris-Melanie ;Vanhoenacker, Filip M ;Vilanova, Joan C ;Tagliafico, Alberto SWeber, Marc-AndréEarly, accurate diagnosis is crucial for the prognosis of patients with soft tissue sarcomas. To this end, standardization of imaging algorithms, technical requirements, and reporting is therefore a prerequisite. Since the first European Society of Musculoskeletal Radiology (ESSR) consensus in 2015, technical achievements, further insights into specific entities, and the revised WHO-classification (2020) and AJCC staging system (2017) made an update necessary. The guidelines are intended to support radiologists in their decision-making and contribute to interdisciplinary tumor board discussions.
